Zhizhong "Joel" Y. - Profile and Investment Details

Investor Profile

Zhizhong "Joel" Y. is a Venture Capital, Investor, Private Equity Firm based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as Noema Pharma, ENYO Pharma, Abivax, Aledia, Genespire, MedDay, CorVent Medical, HighLife, Redx Pharma, Breath Therapeutics, EnginZyme, Asceneuron, Crescendo Biologics, Enthera, AblaCare, DNA Script, Comet Biorefining, Green Biologics, Hookipa Pharma, Inventiva Pharma, CinCor Pharma, GenSight Biologics, SafeHeal, Micropep Technologies, InCarda Therapeutics, AFYX Therapeutics, Sitryx Therapeutics, Pyrowave, Nitrome Biosciences, Delinia, EnobraQ, Pi-Cardia, Twenga, NodThera, HotSpot Therapeutics, Microphyt, Catamaran Bio, Inotrem, Mainstay Medical, Biotalys, Corwave, Rgenix, Synthace, Zyl, Biosyntia, Checkmate Pharmaceuticals, AFYREN, MISSION Therapeutics, Myricx Pharma, CelluComp, Corvidia, ReCor Medical, myTomorrows, Protera, Comet Therapeutics, MD Start, DMC Biotechnologies, Castle Biosciences, Avantium Technologies, Twentyeight-Seven Therapeutics, RefleXion Medical, TISSIUM, Odoo, Shockwave Medical, PinCell s.r.l., Epsilen Bio, LimFlow SA, Erydel, IOmx Therapeutics, ObsEva, Pixium Vision, POLYNEURON. Over time, Zhizhong "Joel" Y. has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Zhizhong "Joel" Y. is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Life Science, Information Technology (IT), Biotech, 3D Technology, Medical Device, Software, Manufacturing, Healthcare, Biotechnology, Genomics, Communities, Financial Services, Medical, Therapeutics, Media and Entertainment, Emergency Medicine, Pharmaceuticals, Sustainability, Biopharma may find it worthwhile to explore potential connections with Zhizhong "Joel" Y., as their portfolio suggests a familiarity and interest in this area.

Understanding Zhizhong "Joel" Y.’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.